Young, R.P.; Scott, R.J.; Callender, T.; Duan, F.; Billings, P.; Aberle, D.R.; Gamble, G.D.
Polygenic Risk Score Is Associated with Developing and Dying from Lung Cancer in the National Lung Screening Trial. J. Clin. Med. 2025, 14, 3110.
https://doi.org/10.3390/jcm14093110
AMA Style
Young RP, Scott RJ, Callender T, Duan F, Billings P, Aberle DR, Gamble GD.
Polygenic Risk Score Is Associated with Developing and Dying from Lung Cancer in the National Lung Screening Trial. Journal of Clinical Medicine. 2025; 14(9):3110.
https://doi.org/10.3390/jcm14093110
Chicago/Turabian Style
Young, Robert P., Raewyn J Scott, Tom Callender, Fenghai Duan, Paul Billings, Denise R. Aberle, and Greg D. Gamble.
2025. "Polygenic Risk Score Is Associated with Developing and Dying from Lung Cancer in the National Lung Screening Trial" Journal of Clinical Medicine 14, no. 9: 3110.
https://doi.org/10.3390/jcm14093110
APA Style
Young, R. P., Scott, R. J., Callender, T., Duan, F., Billings, P., Aberle, D. R., & Gamble, G. D.
(2025). Polygenic Risk Score Is Associated with Developing and Dying from Lung Cancer in the National Lung Screening Trial. Journal of Clinical Medicine, 14(9), 3110.
https://doi.org/10.3390/jcm14093110